Literature DB >> 19286688

Alzheimer's disease and glaucoma: is there a causal relationship?

P Wostyn1, K Audenaert, P P De Deyn.   

Abstract

Evidence of a link between Alzheimer's disease (AD) and glaucoma has emerged from studies showing that patients with AD may have a significantly increased rate of glaucoma occurrence. In addition, it has been reported that patients with AD exhibit optic nerve degeneration and loss of retinal ganglion cells. In spite of intensive research, the clinical and genetic relationships between AD and glaucoma remain obscure. It is unclear whether the clinical correlation between the two diseases might be due to shared risk factors or the influence of one disorder on the other. Interestingly, certain observations may provide a clue towards a better understanding of the high rate of comorbidity reported between AD and glaucoma. In this article, we hypothesise that there may be a causal relationship between AD and glaucoma that may be explained by decreased cerebrospinal fluid pressure (CSFP) in patients with AD. A very recent study reported the intriguing new observation that mean CSFP was 33% lower in subjects with primary open-angle glaucoma than that of non-glaucomatous controls. It was noted that this observation supports the concept that an abnormal high trans-lamina cribrosa pressure difference, whether the result of elevated intraocular pressure, reduced CSFP, or both, plays an important role in glaucomatous optic nerve damage. Interestingly, it was also reported that a substantial proportion of AD patients have very low CSFP. Therefore, we hypothesise that an abnormal high trans-lamina cribrosa pressure difference may explain why patients with AD have a greater risk for developing glaucoma.

Entities:  

Mesh:

Year:  2009        PMID: 19286688     DOI: 10.1136/bjo.2008.148064

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  33 in total

1.  The association between glaucoma prevalence and supplementation with the oxidants calcium and iron.

Authors:  Sophia Y Wang; Kuldev Singh; Shan C Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

2.  Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser422 and Formation of Misfolded Protein Aggregates.

Authors:  John C Means; Adam A Lopez; Peter Koulen
Journal:  Cell Mol Neurobiol       Date:  2020-01-09       Impact factor: 5.046

3.  Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Victor T T Chan; Zihan Sun; Shumin Tang; Li Jia Chen; Adrian Wong; Clement C Tham; Tien Y Wong; Christopher Chen; M Kamran Ikram; Heather E Whitson; Eleonora M Lad; Vincent C T Mok; Carol Y Cheung
Journal:  Ophthalmology       Date:  2018-08-13       Impact factor: 12.079

4.  Genome-wide genetic interaction analysis of glaucoma using expert knowledge derived from human phenotype networks.

Authors:  Ting Hu; Christian Darabos; Maria E Cricco; Emily Kong; Jason H Moore
Journal:  Pac Symp Biocomput       Date:  2015

5.  Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease.

Authors:  Stephanie Toledo Piza Maurano; Delson José da Silva; Marcos P Ávila; Leopoldo Magacho
Journal:  Int Ophthalmol       Date:  2017-07-25       Impact factor: 2.031

6.  An AD-related neuroprotector rescues transformed rat retinal ganglion cells from CoCl₂-induced apoptosis.

Authors:  Jie Men; Xiaohui Zhang; Yang Yang; Dianwen Gao
Journal:  J Mol Neurosci       Date:  2012-01-05       Impact factor: 3.444

Review 7.  Cataract and cognitive impairment: a review of the literature.

Authors:  J M Jefferis; U P Mosimann; M P Clarke
Journal:  Br J Ophthalmol       Date:  2010-08-31       Impact factor: 4.638

8.  Confocal scanning laser tomography of the optic nerve head on the patients with Alzheimer's disease compared to glaucoma and control.

Authors:  Sevda Aydin Kurna; Gokcen Akar; Ahmet Altun; Yasemin Agirman; Eren Gozke; Tomris Sengor
Journal:  Int Ophthalmol       Date:  2014-10-05       Impact factor: 2.031

9.  Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints.

Authors:  Shannon L Risacher; Darrell Wudunn; Susan M Pepin; Tamiko R MaGee; Brenna C McDonald; Laura A Flashman; Heather A Wishart; Heather S Pixley; Laura A Rabin; Nadia Paré; Jessica J Englert; Eben Schwartz; Joshua R Curtain; John D West; Darren P O'Neill; Robert B Santulli; Richard W Newman; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2012-10-18       Impact factor: 4.673

10.  The association between diagnosed glaucoma and cataract and cognitive performance in very old people: cross-sectional findings from the newcastle 85+ study.

Authors:  Joanna M Jefferis; John-Paul Taylor; Joanna Collerton; Carol Jagger; Andrew Kingston; Karen Davies; Tom Kirkwood; Michael P Clarke
Journal:  Ophthalmic Epidemiol       Date:  2013-04       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.